NELDAKIR
Live / Applied — First extension granted (statement of use) (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 19 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99192502
- Mark type
- Stylized text
- Filed
- 19 May 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Christopher M Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders
Owner
- Nuvalent, Inc., Wilmington, DE, US
- Nuvalent, Inc., Cambridge, MA, US
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2026 — SOU EXTENSION 1 GRANTED
- 09 Sept 2026 — SOU EXTENSION 1 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER